News | UAB

Research - News

Breast Cancer Research Foundation of Alabama makes its largest donation yet to UAB

The Breast Cancer Research Foundation of Alabama has presented its largest annual gift to UAB: $400,000.

UAB-HudsonAlpha partner to examine Parkinson’s genes

Currently, there are medications that can ease the symptoms of Parkinson disease, but there is no treatment available to stop the progression of the disease.

Researchers discover gene deletion associated with brain cancer

UAB outreach program to continue with renewed grant

UAB announces vice provost appointments

Why are we getting fatter? UAB researchers seek a mysterious culprit

Novel approach shows promise for cystic fibrosis, say UAB researchers

New study reveals UAB’s $4.6 billion economic impact on state economy

Grant supports new approaches to curbing childhood obesity

Cognitive training can reduce crash risk by half for older drivers

Experimental drug for Hodgkin’s lymphoma shows promise

UAB named national research center to reduce cancer disparities

NSF grant extends UAB research in Antarctica

$11.5 million grant arms UAB Comprehensive Cancer Center fight against pancreatic cancer

The UAB Comprehensive Cancer Center has won an $11.5 million grant to explore pancreatic cancer research, prevention and treatment.

New grant funds research into eye diseases among blacks

Pediatric cancer fellow awarded grant to fight childhood cancers

UAB cybercrime fighters help extend long arm across Alabama

UAB researchers develop new test for shellfish bacteria

UAB psychologist receives grant for autism study

New UAB center is economic development material

UAB researcher selected for inaugural Ovarian Cancer Academy Award

A researcher in the UAB Comprehensive Cancer Center has been selected for the inaugural Ovarian Cancer Academy Award, part of the U.S. Department of Defense funding for cancer research. Assistant Professor Charles Landen, M.D., of the Division of Gynecologic Oncology, is one of seven early career investigators chosen for the grant. The award is $1.06 million from the Office of Congressionally Directed Medical Research.

Landen works to identify and characterize a subpopulation of ovarian cancer cells that have enhanced ability to survive chemotherapy and cause recurrence. Understanding this class of cells may lead to discoveries of key pathways than can be targeted with novel anti-cancer therapies.